L-Lysine-d3 (hydrochloride)

Confirm delete?

L-Lysine-d₃ (hydrochloride)

Zoom

Cat No: 34844

L-Lysine-d3 is intended for use as an internal standard for the quantification of L-lysine by GC- or LC-MS. L-Lysine is an essential amino acid.{62381} It is catabolized via the saccharopine pathway to produce acetyl-coenzyme A (acetyl-CoA; Item No. 1...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

L-lysine-2,6,6-d3, monohydrochloride

Correlated keywords:

FHV1 coenzyme deuterated deuterium GCMS LCMS

Product Overview:
L-Lysine-d3 is intended for use as an internal standard for the quantification of L-lysine by GC- or LC-MS. L-Lysine is an essential amino acid.{62381} It is catabolized via the saccharopine pathway to produce acetyl-coenzyme A (acetyl-CoA; Item No. 16160) in liver mitochondria. L-Lysine is also a precursor in the biosynthesis of L-carnitine (Item No. 21489), a conditionally essential nutrient that has roles in energy production and fatty acid metabolism.{62382} L-Lysine (400 mg/kg per day) reduces viral shedding in cats latently infected with feline herpesvirus type 1 (FHV-1).{62383} Administration of an L-lysine-deficient diet increases fecal pellet excretion induced by restraint stress, indicating increases in anxiety, in rats.{62384} Formulations containing L-lysine have been used as dietary supplements.

Size	1 mg
Shipping	dry ice
CAS Number	2330878-43-6
Molecular Formula	C₆H₁₁D₃N₂O₂ • HCl
SMILES	N[C@](CCCC([2H])([2H])N)([2H])C(O)=O.Cl
Molecular Weight	185,7
Formulation	A solid
Purity	≥99% deuterated forms (d1-d3)
Custom Code	3822.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.